English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Regulatory

+ Regulatory
Jeff Gantt | Dec 24, 2016

Energy and Commerce Committee sees three bills signed into law

+ Community
Jeff Gantt | Dec 24, 2016

Novartis announces acquisition of Ziarco

+ Regulatory
Jeff Gantt | Dec 24, 2016

ANVISA approves Belviq in Brazil

+ Technology/Innovation
Jeff Gantt | Dec 24, 2016

Pfizer releases Paloma-2 sub-analysis study data

+ Regulatory
Jeff Gantt | Dec 24, 2016

European Commission approves Nimenrix for meningococcal disease

+ Community
Keri Carbaugh | Dec 24, 2016

Pfizer’s Ibrance application accepted by FDA

+ Community
Keri Carbaugh | Dec 24, 2016

Sucampo proposes making convertible senior notes available

+ Technology/Innovation
Jeff Gantt | Dec 24, 2016

EMA recommends Keytruda for approval

Trending

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns

  • « First
  • «
  • …
  • 414
  • 415
  • 416
  • 417
  • 418
  • 419
  • 420
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily